Life sciences and healthcare
Overview Insights People
Subscribe to our insights

Publication

The GCR Guide to Life Sciences

October 17, 2024

Life sciences and healthcare

Publication

The GCR Guide to Life Sciences – Product denigration

Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been ...

October 17, 2024

Antitrust and competition
Process of in vitro fertilization in laboratory

Publication

The GCR Guide to Life Sciences – Product denigration

Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been ...

October 17, 2024

Antitrust and competition
AI

Publication

Artificial intelligence and liability: Key takeaways from recent EU legislative initiatives

The EU’s Artificial Intelligence Regulation, commonly referred to as the AI Act, is expected to come into force during t...

July 10, 2024

Artificial intelligence (AI)
european-union-flag

Publication

The European Commission’s prohibition of Illumina's acquisition of GRAIL

On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the adm...

April 17, 2024

Life sciences and healthcare
life-sciences-and-healthcare-drugs-medicine

Publication

The GCR Guide to Life Sciences

October 17, 2024

Life sciences and healthcare
Process of in vitro fertilization in laboratory

Publication

The GCR Guide to Life Sciences – Product denigration

Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been ...

October 17, 2024

Antitrust and competition
AI

Publication

Artificial intelligence and liability: Key takeaways from recent EU legislative initiatives

The EU’s Artificial Intelligence Regulation, commonly referred to as the AI Act, is expected to come into force during t...

July 10, 2024

Artificial intelligence (AI)
european-union-flag

Publication

The European Commission’s prohibition of Illumina's acquisition of GRAIL

On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the adm...

April 17, 2024

Life sciences and healthcare